Загрузка...
Adherence to roflumilast under dose-escalation strategy in Korean patients with COPD
BACKGROUND: Frequent development of adverse events and consequent low adherence are major barriers in the wide use of roflumilast. Asian patients may be more susceptible to adverse events due to low BMI. In this study, we aimed to determine if a dose-escalation strategy is useful to improve the drug...
Сохранить в:
| Опубликовано в: : | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6580853/ https://ncbi.nlm.nih.gov/pubmed/31354255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S191033 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|